Although the National Institutes of Health (NIH) monitor clinical trial enrollment, the agency “has had limited success spurring improvement” in the inclusion of traditionally underrepresented groups, a Department of Health and Human Services (HHS) Office of Inspector General (OIG) report concluded. “Given that the U.S. population continues to diversify and that calls for ens... Read More